Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sheenu Sheela"'
Autor:
Bogdan Popescu, Sheenu Sheela, Julie Thompson, Sophia Grasmeder, Therese Intrater, Christin B. DeStefano, Christopher S. Hourigan, Catherine Lai
Publikováno v:
Clinical Hematology International, Vol 2, Iss 1 (2019)
Therapy for those with relapsed or refractory acute myeloid leukemia is suboptimal. Studies have suggested that timed sequential salvage combination cytotoxic chemotherapy may be particularly useful for that indication. We report here a series of ten
Externí odkaz:
https://doaj.org/article/8895d7cf66054857a40a898735357bb1
Autor:
Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami, Matthew P. Mulé, Nestor R. Ramos, Jingrong Tang, Julie Thompson, Christin B. DeStefano, Kristi Romero, Laura W. Dillon, Dong-Yun Kim, Catherine Lai, Christopher S. Hourigan
Publikováno v:
Frontiers in Oncology, Vol 8 (2019)
Measurable residual disease (MRD) testing after initial chemotherapy treatment can predict relapse and survival in acute myeloid leukemia (AML). However, it has not been established if repeat molecular or genetic testing during chemotherapy can offer
Externí odkaz:
https://doaj.org/article/fa6ebebba15a441496da6f117f43dcad
Autor:
Sheenu Sheela, Sawa Ito, Jeffrey R. Strich, Maura Manion, Celina Montemayor-Garcia, Hao-Wei Wang, Karolyn A. Oetjen, Kamile A. West, Austin J. Barrett, Mark Parta, Juan Gea-Banacloche, Steven M. Holland, Christopher S. Hourigan, Catherine Lai
Publikováno v:
Leukemia Research Reports, Vol 8, Iss C, Pp 4-6 (2017)
Disseminated Fusarium infection is associated with high mortality in immunocompromised patients. Patients with acute myeloid leukemia (AML) often have an extended duration of neutropenia during intensive induction chemotherapy, consolidation chemothe
Externí odkaz:
https://doaj.org/article/533f5c1509fe41648282b4e067751539
Autor:
Anthony D. Sung, Laura W. Dillon, Meghali Goswami, Jingrong Tang, Hong Yuen Wong, Sheenu Sheela, Kristi Romero, Catherine Lai, David A. Rizzieri, Matthew P. Mulé, Nestor R. Ramos, Katherine E. Lindblad, Dong Yun Kim, Christopher S. Hourigan, Christin B. DeStefano, Gregory W. Roloff, Julie D. Thompson
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 8 (2019)
Frontiers in Oncology, Vol 8 (2019)
PURPOSEMeasurable residual disease (MRD) testing after initial chemotherapy treatment can predict relapse and survival in AML. However, it has not been established if repeat molecular or genetic testing during chemotherapy can offer information regar
Autor:
Christopher S. Hourigan, Austin John Barrett, Catherine Lai, Hao-Wei Wang, Mark Parta, Celina Montemayor-Garcia, Maura Manion, Sheenu Sheela, Karolyn A. Oetjen, Steven M. Holland, Kamile A. West, Sawa Ito, Juan Gea-Banacloche, Jeffrey R Strich
Publikováno v:
Leukemia Research Reports, Vol 8, Iss C, Pp 4-6 (2017)
Leukemia Research Reports
Leukemia Research Reports
Disseminated Fusarium infection is associated with high mortality in immunocompromised patients. Patients with acute myeloid leukemia (AML) often have an extended duration of neutropenia during intensive induction chemotherapy, consolidation chemothe
Autor:
Wei Wei, Luke D. Zurbriggen, Kami J. Maddocks, Mohammad K. Khan, Chaitra S. Ujjani, Loretta J. Nastoupil, Nilanjan Ghosh, Boyu Hu, Daniel J. Landsburg, Amy A. Ayers, Adam Kittai, Brad S. Kahl, Alexey V. Danilov, Melody R. Becnel, Sheenu Sheela, Saba Raya, Deborah M. Stephens, Andrew H. Rogers, Vaishalee P. Kenkre, Brian T. Hill, Allison M. Winter, Ryan C. Lynch, Emily C. Ayers, Jonathon B. Cohen
Publikováno v:
Blood. 134:3982-3982
Background: Follicular lymphoma (FL) is the most common indolent lymphoma and is generally characterized by prolonged survival with multiple relapses throughout the disease course. There is no standard of care as to the initial choice or sequencing o
Autor:
Suchitra Sundaram, Jonathan E. Brammer, Adam Zayac, Elvira Umyarova, Paolo Caimi, Waqas Jehangir, Nilanjan Ghosh, Stefan K. Barta, Sheenu Sheela, Adam J. Olszewski, Zachary Braunstein, Sunita D. Nasta, Joanna Rhodes
Publikováno v:
Blood. 134:2854-2854
Introduction: T cell lymphomas are heterogenous with an overall poor prognosis. Peripheral T cell lymphoma not otherwise specified (PTCL-NOS) and angioimmunoblastic T cell lymphoma (AITL) are the two most common subtypes in the US accounting for 45%
Autor:
Christopher S. Hourigan, Sheenu Sheela, Catherine Lai, Julie Thompson, Sophia Grasmeder, Therese Intrater, Christin B. DeStefano, Bogdan Popescu
Publikováno v:
Clinical Hematology International, Vol 2, Iss 1 (2019)
Therapy for those with relapsed or refractory acute myeloid leukemia is suboptimal. Studies have suggested that timed sequential salvage combination cytotoxic chemotherapy may have particular utility for that indication. We report here a series of te
Autor:
Matthew P. Mulé, Catherine Lai, Sheenu Sheela, Kristi Romero, Anthony D. Sung, Christin B. DeStefano, Gregory W. Roloff, Hong Yuen Wong, Laura W. Dillon, Meghali Goswami, Katherine E. Lindblad, David A. Rizzieri, Christopher S. Hourigan
Publikováno v:
Journal of Clinical Oncology. 36:7047-7047
7047Background: Early prediction of response in acute myeloid leukemia (AML) patients undergoing cytotoxic chemotherapy may have clinical utility. Currently, measurable residual disease (MRD) testi...